185 related articles for article (PubMed ID: 30238774)
1. Bactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus.
Letrado P; Corsini B; Díez-Martínez R; Bustamante N; Yuste JE; García P
Future Microbiol; 2018 Sep; 13(11):1215-1223. PubMed ID: 30238774
[TBL] [Abstract][Full Text] [Related]
2. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
[TBL] [Abstract][Full Text] [Related]
3. A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.
Díez-Martínez R; De Paz HD; García-Fernández E; Bustamante N; Euler CW; Fischetti VA; Menendez M; García P
J Antimicrob Chemother; 2015; 70(6):1763-73. PubMed ID: 25733585
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia.
Vouillamoz J; Entenza JM; Giddey M; Fischetti VA; Moreillon P; Resch G
Int J Antimicrob Agents; 2013 Nov; 42(5):416-21. PubMed ID: 23992647
[TBL] [Abstract][Full Text] [Related]
5. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.
Jado I; López R; García E; Fenoll A; Casal J; García P;
J Antimicrob Chemother; 2003 Dec; 52(6):967-73. PubMed ID: 14613958
[TBL] [Abstract][Full Text] [Related]
6. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia.
Loeffler JM; Djurkovic S; Fischetti VA
Infect Immun; 2003 Nov; 71(11):6199-204. PubMed ID: 14573637
[TBL] [Abstract][Full Text] [Related]
7. Improving the lethal effect of cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module.
Díez-Martínez R; de Paz HD; Bustamante N; García E; Menéndez M; García P
Antimicrob Agents Chemother; 2013 Nov; 57(11):5355-65. PubMed ID: 23959317
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.
Corsini B; Díez-Martínez R; Aguinagalde L; González-Camacho F; García-Fernández E; Letrado P; García P; Yuste J
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581113
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae.
Rodríguez-Cerrato V; García P; Huelves L; García E; Del Prado G; Gracia M; Ponte C; López R; Soriano F
Antimicrob Agents Chemother; 2007 Sep; 51(9):3371-3. PubMed ID: 17576844
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotics-resistance pattern and genetic type of Streptococcus pneumoniae isolated from children in Hangzhou].
Hua CZ; Shang SQ; Sun XF; Li JP; Chen ZM; Yu XL
Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):16-9. PubMed ID: 14990098
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci.
Rodríguez-Cerrato V; Del Prado G; Huelves L; Naves P; Ruiz V; García E; Ponte C; Soriano F
Int J Antimicrob Agents; 2010 Jun; 35(6):544-9. PubMed ID: 20303716
[TBL] [Abstract][Full Text] [Related]
12. [Serotype distribution and antibiotic resistance of Streptococcus pneumoniae strains isolated from the adult patients in a Turkish üniversity hospital].
Öksüz L; Gürler N
Mikrobiyol Bul; 2017 Jul; 51(3):195-208. PubMed ID: 28929957
[TBL] [Abstract][Full Text] [Related]
13. SP-CHAP, an endolysin with enhanced activity against biofilm pneumococci and nasopharyngeal colonization.
Alreja AB; Appel AE; Zhu JC; Riley SP; Gonzalez-Juarbe N; Nelson DC
mBio; 2024 Apr; 15(4):e0006924. PubMed ID: 38470268
[TBL] [Abstract][Full Text] [Related]
14. Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model.
Casal J; Aguilar L; Jado I; Yuste J; Giménez MJ; Prieto J; Fenoll A
Antimicrob Agents Chemother; 2002 May; 46(5):1340-4. PubMed ID: 11959566
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
Yenişehirli G; Sener B
Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
[TBL] [Abstract][Full Text] [Related]
16. Beta-lactam modification of the bacteraemic profile and its relationship with mortality in a pneumococcal mouse sepsis model.
Yuste J; Jado I; Fenoll A; Aguilar L; Giménez MJ; Casal J
J Antimicrob Chemother; 2002 Feb; 49(2):331-5. PubMed ID: 11815576
[TBL] [Abstract][Full Text] [Related]
17. Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
Matsumoto Y
Chemotherapy; 1998 Sep; 44 Suppl 1():6-9. PubMed ID: 9797416
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of a penicillin-resistant and tolerable isolate of Streptococcus pneumoniae to combination therapy.
Majhi A; Nandi A; Adhikary R; Mahanti S; Bishayi B
J Infect Dev Ctries; 2015 Jul; 9(7):702-9. PubMed ID: 26230119
[TBL] [Abstract][Full Text] [Related]
19. [Dynamics of Streptococcos pneumoniae antibiotic resistance extension in Moscow in 1998-2003].
Grudinina SA; Sidorenko SV; Fedorchuk VV; Katosova LK; Fatova NA; Eremina LV; Furletova NM; Iutanova NS
Antibiot Khimioter; 2004; 49(4):25-34. PubMed ID: 15460020
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia.
Matarazzo L; Casilag F; Porte R; Wallet F; Cayet D; Faveeuw C; Carnoy C; Sirard JC
Front Immunol; 2019; 10():723. PubMed ID: 31024555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
